Recombinant Human FGF-17 Protein Summary
Product Specifications
Thr23-Thr216, with and without an N-terminal Met
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
319-FG
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 25 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
319-FG/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: FGF-17
FGF‑17 is a member of the fibroblast growth factor (FGF) family. FGFs play multiple roles in biological functions, including angiogenesis, mitogenesis, cell differentiation and wound repair. FGFs share 30‑70% amino acid (aa) identity in a conserved, approximately 120 amino acid core domain (1‑3). The human or mouse FGF‑17 cDNA encodes a cleavable 22 aa signal sequence and a 194 secreted mature protein (1). Mature human FGF‑17 shares 99% aa identity with mouse, rat, porcine and canine FGF‑17. The FGF domain of FGF‑17 shares the most aa identity with FGF‑8 (~75%) and FGF‑18 (~64%). These three FGFs constitute a subfamily that overlaps in some areas of expression and function (1‑5). All are reported to bind and signal through FGF R4 the “c” splice forms of FGF R1‑3 (6, 7). During embryogenesis, FGF‑17 plays an organizing and inducing role in the patterning at the midbrain/hindbrain junction, and is also expressed in hindgut, parts of the developing skeleton, tail bud, major arteries, and heart (2‑5). In many of these areas, it is expressed along with FGF‑8, but slightly later (2‑6). Unlike FGF‑8 and FGF‑18, deletion of FGF‑17 produces viable mice. However, FGF‑17-/- mice show abnormalities in the dorsal frontal cortex, midbrain and cerebellum, manifested in some cases by ataxia, auditory defects, and abnormal social behavior (1, 4, 5, 8, 9). In humans, down‑regulation of FGF‑17 expression has been associated with Dandy‑Walker cerebellar malformation (10). FGF‑17 is also expressed in adult bovine ovarian follicles and the human prostate, and its expression is increased by both benign hypertrophy and cancer of the prostate (11‑13). FGF‑8, FGF‑17, and FGF‑18 are also abnormally expressed in many human leukemic cell lines and can enhance growth of cancer cells (14).
- Itoh, N. and D.M. Ornitz (2008) Dev. Dyn. 237:18.
- Maruoka, Y. et al. (1998) Mech. Dev. 74:175.
- Xu, J. et al. (1999) Mech. Dev. 83:165.
- Cholfin, J.A. and J.L.R. Rubenstein (2007) Proc. Natl. Acad. Sci. USA 104:7652.
- Xu, J. et al. (2000) Development 127:1833.
- Olsen, S.K. et al. (2006) Genes Dev. 20:185.
- Zhang, X. et al. (2006) J. Biol. Chem. 281:15694.
- Yu, X. et al. (2011) Neuroimage 56:1251.
- Scearce-Levie, K. et al. (2008) Genes Brain Behav. 7:344.
- Zanni, G. et al. (2011) Neurogenetics 12:241.
- Machado, M.F. et al. (2009) J. Endocrinol. 202:347.
- Polnaszek, N. et al. (2004) Prostate 60:18.
- Heer, R. et al. (2004) J. Pathol. 204:578.
- Nezu, M. et al. (2005) Biochem. Biophys. Res. Commun. 335:843.
Citation for Recombinant Human FGF-17 Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer.
Authors: Tomlinson DC, Knowles MA
Am. J. Pathol., 2010-10-01;177(5):2379-86.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human FGF-17 Protein
There are currently no reviews for this product. Be the first to review Recombinant Human FGF-17 Protein and earn rewards!
Have you used Recombinant Human FGF-17 Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image